ImmuPharma PLC
F:25I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ImmuPharma PLC
F:25I
|
UK |
|
C
|
Corpfin Capital Prime Retail II Socimi SA
F:F95
|
ES |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
XMUN:LSPP
|
CH |
|
A
|
AIA Group Ltd
XMUN:7A2
|
HK |
|
V
|
Verizon Communications Inc
F:BAC
|
US |
|
O
|
Orion Oyj
DUS:OFK
|
FI |
|
W
|
WuXi AppTec Co Ltd
F:WX8
|
CN |
|
U
|
Uber Technologies Inc
F:UT8
|
US |
|
N
|
Nordhealth AS
F:6E5
|
NO |
|
M
|
Mitsui Fudosan Co Ltd
DUS:MFU
|
JP |
|
R
|
Rolls-Royce Holdings PLC
F:RRU
|
UK |
|
H
|
Helmerich and Payne Inc
F:HPC
|
US |
|
Impala Platinum Holdings Ltd
F:IPH1
|
ZA |
Dividends
Dividend Yield
ImmuPharma PLC
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
ImmuPharma PLC
25I have decreased by 0%.
Payout Ratio
ImmuPharma PLC
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 25I is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
25I Price
ImmuPharma PLC
| Average Annual Return | -19.88% |
| Standard Deviation of Annual Returns | 63.56% |
| Max Drawdown | -88% |
| Market Capitalization | 25.6m EUR |
| Shares Outstanding | 416 437 000 |
| Percentage of Shares Shorted |
N/A
|
